Neurosteroids - from basic research to clinical perspectives

Hormones, Brain and Behavior Online

Volumn , Issue , 2009, Pages 2709-2747

  Frye, C A ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Affect; Allopregnanalone; Alzheimer's; Anxiety; Depression; Estrogen; Lordosis; Menopause; Neurodegeneration; Neurogenesis; Nongenomic; Progesterone; Schizophrenia

Indexed keywords

EID: 84884735960     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008088783-8.00086-3     Document Type: Chapter

References (398)

1. Akwa Y., Baulieu E.E., DeNicola A.F., et al. Steroid synthesis and metabolism in the nervous system: Trophic and protective effects. Journal of Neurocytology 2000, 29:307-326.
2. Altomare G., Capella G.L. Depression circumstantially related to the administration of finasteride for androgenetic alopecia. Journal of Dermatology 2002, 29:665-669.
3. Andréen L., Bixo M., Nyberg S., Sundström-Poromaa I., Bäckström T. Progesterone effects during sequential hormone replacement therapy. European Journal of Endocrinology 2003, 148:571-577.
4. Andréen L., Sundström-Poromaa I., Bixo M., Andersson A., Nyberg S., Bäckström T. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 2005, 30:212-224.
5. Angold A., Costello E.J., Erkanli A. Comorbidity. Journal of Child Psychology and Psychiatry 1999, 40:57-87.
6. Antonijevic I.A., Russell J.A., Bicknell R.J., Leng G., Douglas A.J. Effect of progesterone on the activation of neurones of the supraoptic nucleus during parturition. Journal of Reproduction and Fertility 2000, 120:367-376.
7. Ator N.A., Grant K.A., Purdy R.H., Paul S.M., Griffiths R.R. Drug discrimination analysis of endogenous neuroactive steroids in rats. European Journal of Pharmacology 1993, 241:237-243.
8. Bäckström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurologica Scandinavica 1976, 54:321-347.
9. Bäckström T., Andersson A., Andreé L., et al. Pathogenesis in menstrual cycle-linked CNS disorders. Annals of the New York Academy of Sciences 2003, 1007:42-53.
10. Bäckström T., Sanders D., Leask R., Davidson D., Warner P., Bancroft J. Mood, sexuality, hormones, and the menstrual cycle. II: Hormone levels and their relationship to the premenstrual syndrome. Psychosomatic Medicine 1983, 45:503-507.
11. Baghai T.C., di Michele F., Schüle C., et al. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression. Neuropsychopharmacology 2005, 30:1181-1186.
12. Balthazart J., Baillien M., Cornil C.A., Ball G.F. Preoptic aromatase modulates male sexual behavior: Slow and fast mechanisms of action. Physiology and Behavior 2004, 83:247-270.
13. Barbaccia M.L., Affricano D., Trabucchi M., Purdy R.H., Colombo G., Agabio R., Gessa G.L. Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. European Journal of Pharmacology 1999, 384:1-2.
14. Barbaccia M.L., Roscetti G., Bolacchi F., Concas A., Mostallino M.C., Purdy R.H., Biggio G. Stress-induced increase in brain neuroactive steroids: Antagonism by abecarnil. Pharmacology, Biochemistry, and Behavior 1996, 54:205-210.
15. A receptor function after acute stress. Neuroendocrinology 1996, 63:166-172.
16. Barbaccia M.L., Serra M., Purdy R.H., Biggio G. Stress and neuroactive steroids. International Review of Neurobiology 2001, 46:243-272.
17. Baulieu E.E. Steroid hormone receptors. Exposés Annuels de Biochimie Médicale 1980, 34:1-25.
18. Baulieu E.E. Neurosteroids: A new function in the brain. Biology of the Cell 1991, 71:3-10.
19. Baulieu E.E., Bénavides J., Désarnaud F., et al. Progesterone synthesis and myelin formation in peripheral nerves. Brain Research Reviews 2001, 37:343-359.
20. Baulieu E.E., Schumacher M. Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Human Reproduction 2000, 15:1-13.
21. Beauchamp M.H., Ormerod B.K., Jhamandas K., Boegman R.J., Beninger R.J. Neurosteroids and reward: Allopregnanolone produces a conditioned place aversion in rats. Pharmacology, Biochemistry, and Behavior 2000, 67:29-35.
22. Beck C.A., Wolfe M., Murphy L.D., Wiebe J.P. Acute, nongenomic actions of the neuroactive gonadal steroid, 3α-hydroxy-4-pregnen-20-one (3αHP), on FSH release in perifused rat anterior pituitary cells. Endocrine 1997, 6:221-229.
23. Becker J.B., Cha J.H. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behavioural Brain Research 1989, 35:117-125.
24. Behl C., Holsboer F., Lezoualc'h F., Newton C.J., Post A., Widmann M. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Molecular Pharmacology 1997, 51:535-541.
25. A receptor. Nature Reviews Neuroscience 2005, 6:565-575.
26. Bernardi F., Pieri M., Stomati M., et al. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecological Endocrinology 2003, 17:65-77.
27. Bethea C.L., Lu N.Z., Gundlah C., Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Frontiers in Neuroendocrinology 2002, 23:41-100.
28. A receptor channels from low- to high-efficacy gating patterns. Journal of Neuroscience 2003, 23:10934-10943.
29. Bicíková M., Klak J., Hill M., Zizka Z., Hampl R., Calda P. Two neuroactive steroids in midpregnancy as measured in maternal and fetal sera and in amniotic fluid. Steroids 2002, 67:399-402.
30. Bicíková M., Tallová J., Hill M., Krausová Z., Hampl R. Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder. Neurochemical Research 2000, 25:1623-1627.
31. Billiards S.S., Nguyen P.N., Scheerlinck J.P., Phillips D.J., Canny B.J., Walker D.W., Hirst J.J. Hypoxia potentiates endotoxin-induced allopregnanolone concentrations in the newborn brain. Biology of the Neonate 2006, 90:258-267.
32. Bicikova M., Dibbelt L., Hill M., Hampl R., Starka L. Allopregnanolone in women with premenstrual syndrome. Hormone and Metabolic Research 1998, 30:227-230.
33. Bitran D., Foley M., Audette D., Leslie N., Frye C.A. Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl) 2000, 151:64-71.
34. Bitran D., Hilvers R.J., Kellogg C.K. Anxiolytic effects of 3α-hydroxy-5 α[β]-pregnan-20-one: Endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Research 1991, 561:157-161.
35. Bixo M., Andersson A., Winblad B., Purdy R.H., Bäckström T. Progesterone, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Research 1997, 764:173-178.
36. Björn I., Bäckström T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999, 32:77-86.
37. Björn I., Bixo M., Nöjd K.S., Collberg P., Nyberg S., Sundström-Poromaa I., Bäckström T. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecological Endocrinology 2002, 16:1-8.
38. Björn I., Bixo M., Strandberg-Nöjd K., Nyberg S., Bäckström T. Negative mood changes during hormone replacement therapy - a comparison between two progestogens. American Journal of Obstetrics and Gynecology 2000, 183:1419-1426.
39. Blackham A., Spencer P.S. Response of female mice to anticonvulsants after pretreatment with sex steroids. Journal of Pharmacy and Pharmacology 1970, 22:304-305.
40. Bloch M., Schmidt P.J., Danaceau M., Murphy J., Nieman L., Rubinow D.R. Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry 2000, 157:924-930.
41. Bowen C.A., Purdy R.H., Grant K.A. An investigation of endogenous neuroactive steroid-induced modulation of ethanol's discriminative stimulus effects. Behavioural Pharmacology 1999, 10:297-311.
42. Brambilla F., Biggio G., Pisu M.G., et al. Neurosteroid secretion in panic disorder. Psychiatry Research 2003, 118:107-116.
43. Brinton R.D. Impact of estrogen therapy on Alzheimer's disease: A fork in the road?. CNS Drugs 2004, 18:405-422.
44. Brinton R.D., Chen S., Hsieh D., Minaya J., Montoya M. The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease. Maturitas 2000, 1:34-52.
45. A receptors. European Journal of Pharmacology 1997, 325:1-7.
46. Brown G.W., Harris T.O., Hepworth C., Robinson R. Clinical and psychosocial origins of chronic depressive episodes. II: A patient enquiry. British Journal of Psychiatry 1994, 165:457-465.
47. Brussaard A.B., Herbison A.E. Long-term plasticity of postsynaptic GABAA-receptor function in the adult brain: Insights from the oxytocin neurone. Trends in Neurosciences 2000, 23:190-195.
48. ButzlaffR.L., Hooley J.M. Expressed emotion and psychiatric relapse: A meta-analysis. Archives of General Psychiatry 1998, 55:547-552.
49. Callahan M.J., Lipinski W.J., Bian F., Durham R.A., Pack A., Walker L.C. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. American Journal of Pathology 2001, 158:1173-1177.
50. Calogero A.E., Palumbo M.A., Bosboom A.M., et al. The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acid A receptor. Journal of Endocrinology 1998, 158:121-125.
51. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clinical Obstetrics and Gynecology 1977, 4:31-47.
52. Carroll B.J., Greden J.F., Feinberg M., et al. Neuroendocrine evaluation of depression in borderline patients. Psychiatric Clinics of North America 1981, 4:89-99.
53. Carlsson M.L. Hypothesis: Is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy. Journal of Neural Transmission 1998, 105:525-535. Review.
54. Chaban V.V., Lakhter A.J., Micevych P. A membrane estrogen receptor mediates intracellular calcium release in astrocytes. Endocrinology 2004, 145:3788-3795.
55. Chan J.R., Phillips L.J., Glaser M. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:10459-10464.
56. Chappell P.E., Levine J.E. Stimulation of gonadotropin-releasing hormone surges by estrogen. I: Role of hypothalamic progesterone receptors. Endocrinology 2000, 141:1477-1485.
57. Charalampopoulos I., Tsatsanis C., Dermitzaki E., Alexaki V.I., Castanas E., Margioris A.N., Gravanis A. Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:8209-8214.
58. Chaudron L.H., Klein M.H., Remington P., Palta M., Allen C., Essex M.J. Predictors, prodromes and incidence of postpartum depression. Journal of Psychosomatic Obstetrics and Gynecology 2001, 22:103-112.
59. Chen K., Kandel D. Relationship between extent of cocaine use and dependence among adolescents and adults in the United States. Drug and Alcohol Dependence 2002, 68:65.
60. Cheng J., Karavolas H.J. Conversion of progesterone to 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one by rat medical basal hypothalami and the effects of estradiol and stage of estrous cycle on the conversion. Endocrinology 1973, 93:1157-1162.
61. Ciriza I., Carrero P., Frye C.A., Garcia-Segura L.M. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. Journal of Neurobiology 2006, 66:916-928.
62. Clifford G.M., Farmer R.D. Drug or symptom-induced depression in men treated with α 1-blockers for benign prostatic hyperplasia? A nested case-control study. Pharmacoepidemiology and Drug Safety 2002, 11:55-61.
63. Compagnone N.A., Mellon S.H. Neurosteroids: Biosynthesis and function of these novel neuromodulators. Frontiers in Neuroendocrinology 2000, 21:1-56.
64. Concas A., Mostallino M.C., Porcu P., et al. Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:13284-13289.
65. Cooper D.C. The significance of action potential bursting in the brain reward circuit. Neurochemistry International 2002, 41:333-340.
66. Costa P.J., Bonnycastle D.D. The effect of DCA compound E testosterone, progesterone and ACTH in modifying agene-induced convulsions in dogs. Archives Internationales de Pharmacodynamie et de Thérapie 1952, 91:330-338.
67. Crossley K.J., Nicol M.B., Hirst J.J., Walker D.W., Thorburn G.D. Suppression of arousal by progesterone in fetal sheep. Reproduction, Fertility, and Development 1997, 9:767-773.
68. Deminière J.M., Piazza P.V., Guegan G., Abrous N., Maccari S., Le Moal M., Simon H. Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Research 1992, 586:135-139.
69. DitkoffE.C., Crary W.G., Cristo M., Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstetrics and Gynecology 1991, 18:991-995.
70. Dong E., Matsumoto K., Uzunova V., et al. Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:2849-2854.
71. Dray A. Serotonin in the basal ganglia: Functions and interactions with other neuronal pathways. Journal of Physiology, Paris 1981, 77:393-403. Review.
72. Dubrovsky B. Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacology, Biochemistry, and Behavior 2006, 84:644-655.
73. Ebner M.J., Corol D.I., Havlíková H., Honour J.W., Fry J.P. Identification of neuroactive steroids and their precursors and metabolites in adult male rat brain. Endocrinology 2006, 147:179-190.
74. El-Etr M., Akwa Y., Fiddes R.J., Robel P., Baulieu E.E. A progesterone metabolite stimulates the release of gonadotropin-releasing hormone from GT1-1 hypothalamic neurons via the gamma-aminobutyric acid type A receptor. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:3769-3773.
75. Endicott J., Amsterdam J., Eriksson E., et al. Is premenstrual dysphoric disorder a distinct clinical entity?. Journal of Women's Health and Gender-Based Medicine 1999, 8:663-679.
76. Engel S.R., Grant K.A. Neurosteroids and behavior. International Review of Neurobiology 2001, 46:321-348.
77. Epperson C.N., Haga K., Mason G.F., et al. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: A proton magnetic resonance spectroscopy study. Archives of General Psychiatry 2002, 59:851-858.
78. Erskine M.S., Kornberg E. Stress and ACTH increase circulating concentrations of 3 α-androstanediol in female rats. Life Sciences 1992, 51:2065-2071.
79. Eser D., di Michele F., Zwanzger P., et al. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3α, 5α tetrahydrodeoxycorticosterone (3α, 5α-THDOC) in healthy volunteers. Neuropsychopharmacology 2005, 30:192-195.
80. Finn D.A., Phillips T.J., Okorn D.M., Chester J.A., Cunningham C.L. Rewarding effect of the neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in mice. Pharmacology, Biochemistry, and Behaviour 1997, 56:261-264.
81. Fish E.W., Faccidomo S., DeBold J.F., Miczek K.A. Alcohol, allopregnanolone and aggression in mice. Psychopharmacology (Berl) 2001, 153:473-483.
82. Fleming A.S., Rosenblatt J.S. Maternal behavior in the virgin and lactating rat. Journal of Comparative Physiology 1974, 86:957-972.
83. Freeman E.W., Sammel M.D., Lin H., Gracia C.R., Kapoor S. Symptoms in the menopausal transition: Hormone and behavioral correlates. Obstetrics and Gynecology 2008, 111:127-136.
84. Frye C.A. The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Research Review 2001, 37:201-222.
85. Frye C.A. The role of neurosteroids and nongenomic effects of progestins in the ventral tegmental area in mediating sexual receptivity of rodents. Hormones and Behavior 2001, 40:226-233.
86. Frye C.A. Role of androgens in epilepsy. Expert Review of Neurotherapeutics 2006, 6:1061-1075.
87. Frye C.A. Some rewarding effects of androgens may be mediated by actions of its 5α-reduced metabolite 3α-androstanediol. Pharmacology, Biochemistry, and Behavior 2007, 86:354-367.
88. Frye C.A. Hormonal influences on seizures: Basic neurobiology. Epilepsy in Women-Scientific Management. International Review of Neurobiology 2008, vol. 83:27-77. Academic Press, London. B.E. Gidal, C. Harding (Eds.).
89. Frye C.A. Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacology, Biochemistry, and Behavior 2008, 86:209-219.
90. Frye C.A., Bayon L.E. Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha,5 alpha THP. Neuroendocrinology 1998, 68:272-280. Erratum in: Neuroendocrinology 1998 Dec;68(6): 436.
91. Frye C.A., Bayon L.E. Mating stimuli influence endogenous variations in the neurosteroids 3alpha,5alpha-THP and 3alpha-Diol. Journal of Neuroendocrinology 1999, 11:839-847.
92. Frye C.A., Paris J.J., Rhodes M.E. Engaging in paced mating, but neither exploratory, anti-anxiety, nor social behavior, increases 5α-reduced progestin concentrations in midbrain, hippocampus, striatum, and cortex. Reproduction 2007, 133:663-674.
93. Frye C.A., Petralia S.M., Rhodes M.E. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3alpha,5alpha-THP. Pharmacology, Biochemistry, and Behavior 2000, 67:587-596.
94. Frye C.A., Rhodes M.E. Reciprocal effects of exploration, anxiety, social, and sexual behaviors and progestins in midbrain, hippocampus, diencephalon, and cortex. Evolutionary Molecular Strategies and Plasticity 2007, 237-260. Research Signpost, Kerala, India. M. Canonaco, R.M. Facciolo (Eds.).
95. Frye C.A., Rhodes M.E. Infusions of 3α,5α-THP to the VTA enhance exploratory, anti-anxiety, social, and sexual behavior and increase levels of 3α,5α-THP in midbrain, hippocampus, diencephalon, and cortex of female rats. Behavioural Brain Research 2008, 187:88-99.
96. Frye C.A., Rhodes M.E. The role and mechanisms of steroid hormones to enhance approach behavior. Handbook of Approach and Avoidance Motivation 2008, 109-126. LEA, Mahwah, NJ. A. Elliot (Ed.).
97. Frye C.A., Rhodes M.E. The role of midbrain 3alpha,5alpha-THP in mediating exploration, anxiety, social and reproductive behavior. Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies for Research and Treatment 2008, 449-482. Springer Science, New York. R.S. Michael, W. Abraham (Eds.).
98. Frye C.A., Rhodes M.E., Petralia S.M., Walf A.A., Sumida K., Edinger K.L. 3α-Hydroxy-5α-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors. Neuroscience 2006, 138:1007-1014.
99. Frye C.A., Scalise T.J. Anti-seizure effects of progesterone and 3alpha,5alpha-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 2000, 25:407-420.
100. Frye C.A., Scalise T.J., Bayon L.E. Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity. Journal of Neuroendocrinology 1998, 10:291-296.
101. Frye C.A., Seliga A.M. Olanzapine's effects to reduce fear and anxiety and enhance social interactions coincide with increased progestin concentrations of ovariectomized rats. Psychoneuroendocrinology 2003, 28:657-673.
102. Frye C.A., Walf A.A. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Hormones and Behavior 2002, 41:306-315.
103. Frye C.A., Walf A.A. Hippocampal 3alpha,5alpha-THP may alter depressive behavior of pregnant and lactating rats. Pharmacology, Biochemistry, and Behavior 2004, 78:531-540.
104. Frye C.A., Walf A.A. Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice. Neurobiology of Learning and Memory 2008, 89:17-26.
105. A receptors involve downstream signal transduction pathways. Steroids 2008, 73:906-913.
106. Frye C.A., Wawrzycki J. Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Hormones and Behavior 2003, 44:319-326.
107. Frye C.A., Walf A.A., Rhodes M.E., Harney J.P. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5 alpha-reductase. Brain Research 2004, 1004:116-124.
108. Furukawa A., Miyatake A., Ohnishi T., Ichikawa Y. Steroidogenic acute regulatory protein (StAR) transcripts constitutively expressed in the adult rat central nervous system: Colocalization of StAR, cytochrome P-450SCC (CYP XIA1), and 3β-hydroxysteroid dehydrogenase in the rat brain. Journal of Neurochemistry 1998, 71:2231-2238.
109. Gabriel K.I., Cunningham C.L., Finn D.A. Allopregnanolone does not influence ethanol-induced conditioned place preference in DBA/2J mice. Psychopharmacology (Berl) 2004, 176:50-56.
110. Galea L.A. Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents. Brain Research Reviews 2008, 57:332-341.
111. Gee K.W., McCauley L.D., Lan N.C. A putative receptor for neurosteroids on the GABAA receptor complex: The pharmacological properties and therapeutic potential of epalons. Critical Reviews in Neurobiology 1995, 9:207-227.
112. Genazzani A.R., Palumbo M.A., deMicheroux A.A., et al. Evidence for a role for the neurosteroid allopregnanolone in the modulation of reproductive function in female rats. European Journal of Endocrinology 1995, 133:375-380.
113. Genazzani A.R., Petraglia F., Bernardi F., et al. Circulating levels of allopregnanolone in humans: Gender, age, and endocrine influences. Journal of Clinical Endocrinology and Metabolism 1998, 83:2099-2103.
114. Genazzani A.R., Stomati M., Bernardi F., et al. Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and β-endorphin levels in female rats. Fertility and Sterility 2004, 81:757-766.
115. Girdler S.S., Straneva P.A., Light K.C., Pedersen C.A., Morrow A.L. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biological Psychiatry 2001, 49:788-797.
116. Glick I.D., Bennett S.E. Psychiatric complications of progesterone and oral contraceptives. Journal of Clinical Psychopharmacology 1981, 1:350-367.
117. Grant K.A., Azarov A., Bowen C.A., Mirkis S., Purdy R.H. Ethanol-like discriminative stimulus effects of the neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in female Macaca fascicularis monkeys. Psychopharmacology (Berl) 1996, 124(4):340-346.
118. Griffin L.D., Mellon S.H. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:13512-13517.
119. Guidotti A., Costa E. Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3α, 5α-tetrahydroprogesterone (allopregnanolone) availability?. Biological Psychiatry 1998, 44:865-873.
120. Guidotti A., Dong E., Matsumoto K., Pinna G., Rasmusson A.M., Costa E. The socially-isolated mouse: A model to study the putative role of allopregnanolone and 5α-dihydroprogesterone in psychiatric disorders. Brain Research Reviews 2001, 37:110-115.
121. Gulinello M., Orman R., Smith S.S. Sex differences in anxiety, sensorimotor gating and expression of the α4 subunit of the GABA receptor in the amygdala after progesterone withdrawal. European Journal of Neuroscience 2003, 17:641-648.
122. Haage D., Bäckström T., Johansson S. Interaction between allopregnanolone and pregnenolone sulfate in modulating GABA-mediated synaptic currents in neurons from the rat medial preoptic nucleus. Brain Research 2005, 1033:58-67.
123. Halbreich U., Bancroft J., Dennerstein L., et al. Menstrually related disorders: Points of consensus, debate, and disagreement. Neuropsychopharmacology 1993, 9:13-15. (discussion 17-29).
124. Halbreich U., Endicott J., Lesser J. The clinical diagnosis and classification of premenstrual changes. Canadian Journal of Psychiatry 1985, 30:489-497.
125. Hallonquist J.D., Seeman M.V., Lang M., Rector N.A. Variation in symptom severity over the menstrual cycle of schizophrenics. Biological Psychiatry 1993, 33:207-209.
126. Hammarbäck S., Bäckström T. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstetricia et Gynecologica Scandinavica 1988, 67:159-166.
127. Hammarbäck S., Bäckström T., Holst J., von Schoultz B., Lyrenäs S. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstetricia et Gynecologica Scandinavica 1985, 64:393-397.
128. Hammarbäck S., Bäckström T., MacGibbon-Tyler B. Diagnosis of pre-menstrual syndrome: Description and evaluation of a procedure for diagnosis and differential diagnosis. Journal of the International Society of Psychosomatic Obstetrics and Gynecology 1989, 10:25-42.
129. Hammarbäck S., Ekholm U.B., Bäckström T. Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinologica (Copenh) 1991, 125:132-137.
130. Harrison N.L., Simmonds M.A. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Research 1984, 323:287-292.
131. Haug M., Brain P.F. The effects of differential housing, castration and steroidal hormone replacement on attacks directed by resident mice towards lactating intruders. Physiology and Behavior 1983, 30:557-560.
132. Hellsten J., Wennström M., Bengzon J., Mohapel P., Tingström A. Electroconvulsive seizures induce endothelial cell proliferation in adult rat hippocampus. Biological Psychiatry 2004, 55:420-427.
133. Hellsten J., Wennström B., Mohapel P., Ekdahl C., Bengzon J., Tingström A. Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment. European Journal of Neuroscience 2002, 16:283-290.
134. Hendrick V., Altshuler L.L., Burt V.K. Course of psychiatric disorders across the menstrual cycle. Harvard Review of Psychiatry 1996, 4:200-207.
135. Herbison A.E. Physiological roles for the neurosteroid allopregnanolone in the modulation of brain function during pregnancy and parturition. Progress in Brain Research 2001, 133:39-47.
136. Herzog A.G. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 1995, 45:1660-1662.
137. Herzog A.G., Frye C.A. Seizure exacerbation associated with inhibition of progesterone metabolism. Annals of Neurology 2003, 53:390-391.
138. Hevers W., Lüddens H. The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Molecular Neurobiology 1998, 18:35-86.
139. Hirani K., Khisti R.T., Chopde C.T. Behavioral action of ethanol in Porsolt's forced swim test: Modulation by 3α-hydroxy-5α-pregnan-20-one. Neuropharmacology 2002, 43:1339-1350.
140. Hirst J.J., Palliser H.K., Yates D.M., Yawno T., Walker D.W. Neurosteroids in the fetus and neonate: Potential protective role in compromised pregnancies. Neurochemistry International 2008, 52:602-610.
141. Holmes G.L., Albala B.J., Moshé S.L. Effect of a single brief seizure on subsequent seizure susceptibility in the immature rat. Archives of Neurology 1984, 41:853-855.
142. Holzbauer M., Birmingham M.K., De Nicola A.F., Oliver J.T. In vivo secretion of 3 alpha-hydroxy-5 alpha-pregnan-20-one, a potent anaesthetic steroid, by the adrenal gland of the rat. Journal of Steroid Biochemistry 1985, 22:97-102.
143. Hornykiewicz O. Neurohumoral interactions and basal ganglia function and dysfunction. Research Publications: Association for Research in Nervous and Mental Disease 1976, 55:269-280.
144. Huber T.J., Rollnik J., Wilhelms J., von zur Muhlen A., Emrich H.M., Schneider U. Estradiol levels in psychotic disorders. Psychoneuroendocrinology 2001, 26:27-35.
145. Huddleston G.G., Michael R.P., Zumpe D., Clancy A.N. Estradiol in the male rat amygdala facilitates mounting but not ejaculation. Physiology and Behavior 2003, 79:239-246.
146. Huddleston G.G., Paisley J.C., Clancy A.N. Effects of estrogen in the male rat medial amygdala: Infusion of an aromatase inhibitor lowers mating and bovine serum albumin-conjugated estradiol implants do not promote mating. Neuroendocrinology 2006, 83:106-116.
147. Jain N.S., Hirani K., Chopde C.T. Reversal of caffeine-induced anxiety by neurosteroid 3-α-hydroxy-5-α-pregnane-20-one in rats. Neuropharmacology 2005, 48:627-638.
148. Janak P.H., Redfern J.E., Samson H.H. The reinforcing effects of ethanol are altered by the endogenous neurosteroid, allopregnanolone. Alcoholism, Clinical and Experimental Research 1998, 22:1106-1112.
149. Jayanthi S., Deng X., Noailles P.A., Ladenheim B., Cadet J.L. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB Journal 2004, 18:238-251.
150. Jenkins W.J., Becker J.B. Female rats develop conditioned place preferences for sex at their preferred interval. Hormones and Behavior 2003, 43:503-507.
151. Johnson S.D., Striley C., Cottler L.B. The association of substance use disorders with trauma exposure and PTSD among African American drug users. Addictive Behaviors 2006, 31:2063-2073.
152. Kavaliers M. Inhibitory influences of the adrenal steroid, 3α,5α-tetrahydrodeoxycorticosterone (correction of tetrahydroxycorticosterone) on aggression and defeat-induced analgesia in mice. Psychopharmacology (Berl) 1988, 95:488-492.
153. Kavaliers M., Kinsella D.M. Male preference for the odors of estrous female mice is reduced by the neurosteroid pregnenolone sulfate. Brain Research 1995, 682:222-226.
154. Kehoe P., Mallinson K., McCormick C.M., Frye C.A. Central allopregnanolone is increased in rat pups in response to repeated, short episodes of neonatal isolation. Developmental Brain Research 2000, 124:133-136.
155. Kellogg C.K., Frye C.A. Endogenous levels of 5α-reduced progestins and androgens in fetal vs. adult rat brains. Developmental Brain Research 1999, 115:17-24.
156. Kessler R.C., McGonagle K.A., Nelson C.B., Hughes M., Swartz M., Blazer D.G. Sex and depression in the National Comorbidity Survey. II: Cohort effects. Journal of Affective Disorders 1994, 30:15-26.
157. Khisti R.T., Chopde C.T., Jain S.P. Antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice forced swim test. Pharmacology, Biochemistry, and Behavior 2000, 67:137-143.
158. Khisti R.T., Kumar S., Morrow A.L. Ethanol rapidly induces steroidogenic acute regulatory protein expression and translocation in rat adrenal gland. European Journal of Pharmacology 2003, 473:225-227.
159. Khisti R.T., Penland S.N., VanDoren M.J., Grobin A.C., Morrow A.L. GABAergic neurosteroid modulation of ethanol actions. World Journal of Biological Psychiatry 2002, 3:87-95.
160. King S.R., Matassa A.A., White E.K., et al. Oxysterols regulate expression of the steroidogenic acute regulatory protein. Journal of Molecular Endocrinology 2004, 32:507-517.
161. Koenig H.L., Schumacher M., Ferzaz B., et al. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500-1503.
162. Koschel K., Tas P.W.I. Lysophosphatidic acid reverts the β-adrenergic agonist-induced morphological response in C6 rat glioma cells. Experimental Cell Research 1993, 206:162-166.
163. Kríz L., Bicíková M., Hill M., Hampl R. Steroid sulfatase and sulfuryl transferase activity in monkey brain tissue. Steroids 2005, 70:960-969.
164. Kurumaji A., Nomoto H., Yoshikawa T., Okubo Y., Toru M. An association study between two missense variations of the benzodiazepine receptor (peripheral) gene and schizophrenia in a Japanese sample. Journal of Neural Transmission 2000, 107:491-500.
165. Laconi M.R., Cabrera R.J. Effect of centrally injected allopregnanolone on sexual receptivity, luteinizing hormone release, hypothalamic dopamine turnover, and release in female rats. Endocrine 2002, 17:77-83.
166. A receptors. Progress in Neurobiology 2003, 71:67-80.
167. Lan N.C., Gee K.W. Neuroactive steroid actions at the GABAA receptor. Hormones and Behavior 1994, 28:537-544.
168. Lancel M., Faulhaber J., Holsboer F., Rupprecht R. Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. American Journal of Physiology 1996, 271:E763-E772.
169. Lancefield K., Nosarti C., Rifkin L., Allin M., Sham P., Murray R. Cerebral asymmetry in 14 year olds born very preterm. Brain Research 2006, 1093:33-40.
170. Landgren S., Aasly J., Bäckström T., Dubrovsky B., Danielsson E. The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiologica Scandinavica 1987, 131:33-42.
171. Landgren S., Bäckström T., Kalistratov G. The effect of progesterone on the spontaneous interictal spike evoked by the application of penicillin to the cat's cerebral cortex. Journal of the Neurological Sciences 1978, 36:119-133.
172. Latkin C.A., Curry A.D., Hua W., Davey M.A. Direct and indirect associations of neighborhood disorder with drug use and high-risk sexual partners. American Journal of Preventive Medicine 2007, 32(Supplement 6):S234-S241.
173. LeMellédo J.M., Baker G.B. Neuroactive steroids and anxiety disorders. Journal of Psychiatry and Neuroscience 2002, 27:161-165.
174. LePrince G., Fages C., Rolland B., Nunez J., Tardy M. cAMP effect on the expression of GFAP and of its encoding mRNA in astroglial primary cultures. Glia 1991, 4:322-326.
175. Li Y., Liu L., Barger S.W., Mrak R.E., Griffin W.S. Vitamin E suppression of microglial activation is neuroprotective. Journal of Neuroscience Research 2001, 66:163-170.
176. Liere P., Pianos A., Eychenne B., et al. Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain. Journal of Lipid Research 2004, 45:2287-2302.
177. Liu T., Wimalasena J., Bowen R.L., Atwood C.S. Luteinizing hormone receptor mediates neuronal pregnenolone production via up-regulation of steroidogenic acute regulatory protein expression. Journal of Neurochemistry 2007, 100:1329-1339.
178. Luisi S., Petraglia F., Benedetto C., et al. Serum allopregnanolone levels in pregnant women: Changes during pregnancy, at delivery, and in hypertensive patients. Journal of Clinical Endocrinology and Metabolism 2000, 85:2429-2433.
179. LukoffD., Snyder K., Ventura J., Nuechterlein K.H. Life events, familial stress, and coping in the developmental course of schizophrenia. Schizophrenia Bulletin 1984, 10:258-292.
180. Maayan R., Fisch B., Galdor M., et al. Influence of 17β-estradiol on the synthesis of reduced neurosteroids in the brain (in vivo) and in glioma cells (in vitro): Possible relevance to mental disorders in women. Brain Research 2004, 1020:167-172.
181. Maayan R., Strous R.D., Abou-Kaoud M., Weizman A. The effect of 17β estradiol withdrawal on the level of brain and peripheral neurosteroids in ovarectomized rats. Neuroscience Letters 2005, 384:156-161.
182. MacLennan A., Lester S., Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews 2001, CD002978. 10.1002/14651858.CD002978.pub2.
183. Magnaghi V., Cavarretta I., Galbiati M., Martini L., Melcangi R.C. Neuroactive steroids and peripheral myelin proteins. Brain Research - Brain Research Reviews 2001, 37:360-371. Review.
184. Magos A.L., Brewster E., Sing R., O'Dowd T.M., Studd J.W.W. The effect of norethisterone in postmenopausal women on oestrogen therapy: A model for the premenstrual syndrome. British Journal of Obstetrics and Gynaecology 1986, 93:1290-1296.
185. A receptor. Mechanism of action and physiological significance. Progress in Neurobiology 1992, 38:379-395.
186. Majewska M.D., Demirgören S., London E.D. Binding of pregnenolone sulfate to rat brain membranes suggests multiple sites of steroid action at the GABAA receptor. European Journal of Pharmacology 1990, 189:307-315.
187. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986, 232:1004-1007.
188. Majewska M.D., Schwartz R.D. Pregnenolone-sulfate: An endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain?. Brain Research 1987, 404:355-360.
189. Malla A.K., Cortese L., Shaw T.S., Ginsberg B. Life events and relapse in schizophrenia. A one year prospective study. Social Psychiatry and Psychiatric Epidemiology 1999, 25:221-224.
190. Mann P.E. Finasteride delays the onset of maternal behavior in primigravid rats. Physiology and Behavior 2006, 88:333-338.
191. Marcondes F.K., Miguel K.J., Melo L.L., Spadari-Bratficsh R.C. Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiology and Behavior 2001, 74:435-440.
192. Markou A., Duka T., Prelevic G.M. Estrogens and brain function. Hormones (Athens) 2005, 4:9-17.
193. Martin-Garcia E., Pallares M. The intrahippocampal administration of the neurosteroid allopregnanolone blocks the audiogenic seizures induced by nicotine. Brain Research 2005, 1062:144-150.
194. Marx C.E., Duncan G.E., Gilmore J.H., Lieberman J.A., Morrow A.L. Olanzapine increases allopregnanolone in the rat cerebral cortex. Biological Psychiatry 2000, 47:1000-1004.
195. Marx C.E., Lieberman J.A. Psychoneuroendocrinology of schizophrenia. Psychiatric Clinics of North America 1998, 21:413-434.
196. Matsumoto K., Pinna G., Puia G., Guidotti A., Costa E. Social isolation stress-induced aggression in mice: A model to study the pharmacology of neurosteroidogenesis. Stress 2005, 8:85-93.
197. McCormick C.M., Kehoe P., Mallinson K., Cecchi L., Frye C.A. Neonatal isolation alters stress hormone and mesolimbic dopamine release in juvenile rats. Pharmacology, Biochemistry, and Behavior 2002, 73:77-85.
198. McFarlane H.G., Kusek G.K., Yang M., Phoenix J.L., Bolivar V.J., Crawley J.N. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain and Behavior 2008, 7:152-163.
199. McKay J.R., Rutherford M.J., Alterman A.I., Cacciola J.S., Kaplan M.R. An examination of the cocaine relapse process. Drug and Alcohol Dependence 1995, 38:35-43.
200. Mehta A.K., Ticku M.K. An update on GABAA receptors. Brain research. Brain Research Reviews 1999, 29:196-217.
201. Melcangi R.C., Celotti F., Castano P., Martini L. Intracellular signaling systems controlling the 5α-reductase in glial cell cultures. Brain Research 1992, 585:411-415.
202. Melcangi R.C., Panzica G. Steroids and the nervous system. Introduction. Annals of the New York Academy of Sciences 2003, 1007:1-5.
203. Mellon S.H. Neurosteroids: Biochemistry, modes of action, and clinical relevance. Journal of Clinical Endocrinology and Metabolism 1994, 78:1003-1008. Review.
204. Mellon S.H. Neurosteroid regulation of central nervous system development. Pharmacology and Therapeutics 2007, 6:107-124.
205. Mellon S.H., Deschepper C.F. Neurosteroid biosynthesis: Genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Research 1993, 3:283-292.
206. Mellon S.H., Griffin L.D., Compagnone N.A. Biosynthesis and action of neurosteroids. Brain Research - Brain Research Reviews 2001, 37:3-12. Review.
207. Micevych P., Sinchak K., Mills R.H., Tao L., LaPolt P., Lu J.K. The luteinizing hormone surge is preceded by an estrogen-induced increase of hypothalamic progesterone in ovariectomized and adrenalectomized rats. Neuroendocrinology 2003, 78:29-35.
208. Miczek K.A., Fish E.W., DeBold J.F. Neurosteroids, GABAA receptors, and escalated aggressive behavior. Hormones and Behavior 2003, 44:242-257.
209. Monnet F.P., Mahé V., Robel P., Baulieu E.E. Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-d-aspartate in the rat hippocampus. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:3774-3778.
210. Monteleone P., Luisi S., Tonetti A., Bernardi F., Genazzani A.D., Luisi M., Petraglia F., Genazzani A.R. Allopregnanolone concentrations and premenstrual syndrome. European Journal of Endocrinology 2000, 142:269-273.
211. More L. Mouse major urinary proteins trigger ovulation via the vomeronasal organ. Chemical Senses 2006, 31:393-401.
212. Morita K., Arimochi H., Tsuruo Y. Adrenergic activation of steroid 5α-reductase gene expression in rat C6 glioma cells: Involvement of cyclic AMP/protein kinase A-mediated signaling pathway. Journal of Molecular Neuroscience 2004, 22:205-212.
213. Morita K., Hideki A., Hiroyuki I., Song H. Possible involvement of 5α-reduced neurosteroids in adrenergic and serotonergic stimulations of GFAP gene expression in rat C6 glioma cells. Brain Research 2006, 1085:49-56.
214. Morrow A.L., Janis G.C., VanDoren M.J., Matthews D.B., Samson H.H., Janak P.H., Grant K.A. Neurosteroids mediate pharmacological effects of ethanol: A new mechanism of ethanol action?. Alcoholism: Clinical and Experimental Research 1999, 23:1933-1940.
215. Morrow A.L., Suzdak P.D., Paul S.M. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. European Journal of Pharmacology 1987, 142:483-485.
216. Morrow A.L., VanDoren M.J., Penland S.N., Matthews D.B. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Research - Brain Research Reviews 2001, 37:98-109. Review.
217. Moy S.S., Nadler J.J., Young N.B., et al. Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains. Behavioural Brain Research 2007, 176:4-20.
218. Myin-Germeys I., van OsJ., Schwartz J.E., Stone A.A., Delespaul P.A. Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry 2001, 58:1137-1144.
219. NemeroffC.B. The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 1988, 21:76-82.
220. Nguyen P.N., Billiards S.S., Walker D.W., Hirst J.J. Changes in 5alpha-pregnane steroids and neurosteroidogenic enzyme expression in the perinatal sheep. Pediatric Research 2003, 53:956-964.
221. Nguyen P.N., Billiards S.S., Walker D.W., Hirst J.J. Changes in 5alpha-pregnane steroids and neurosteroidogenic enzyme expression in fetal sheep with umbilicoplacental embolization. Pediatric Research 2003, 54:840-847.
222. Nguyen P.N., Ross Young I., Walker D.W., Hirst J.J. Allopregnanolone in the brain and blood after disruption of the hypothalamic-pituitary-adrenal axis in fetal sheep. Journal of Endocrinology 2004, 182:81-88.
223. A receptor antagonists in the late gestation fetal sheep. Neuropharmacology 1999, 38:49-63.
224. Nie H., Janak P.H. Comparison of reinstatement of ethanol - and sucrose-seeking by conditioned stimuli and priming injections of allopregnanolone after extinction in rats. Psychopharmacology (Berl) 2003, 168:222-228.
225. Norman R.M., Malla A.K. Stressful life events and schizophrenia. I: A review of the research. British Journal of Psychiatry 1993, 162:161-166.
226. Nosarti C., Al-Asady M.H., Frangou S., Stewart A.L., Rifkin L., Murray R.M. Adolescents who were born very preterm have decreased brain volumes. Brain 2002, 125(Pt 7):1616-1623.
227. Nosarti C., Rushe T.M., WoodruffP.W., Stewart A.L., Rifkin L., Murray R.M. Corpus callosum size and very preterm birth: Relationship to neuropsychological outcome. Brain 2004, 127(Pt 9):2080-2089.
228. Numan M., Insel T.R. Motivational models of the onset and maintenance of maternal behavior and maternal aggression, the neurobiology of parental behavior. The Neurobiology of Parental Behavior 2003, 69-107. Springer, New York.
229. O'Brien C.P., Childress A.R., Ehrman R., Robbins S.J. Conditioning factors in drug abuse: Can they explain compulsion?. Journal of Psychopharmacology 1998, 12:15-22.
230. O'Dell L.E., Alomary A.A., Vallée M., Koob G.F., Fitzgerald R.L., Purdy R.H. Ethanol-induced increases in neuroactive steroids in the rat brain and plasma are absent in adrenalectomized and gonadectomized rats. European Journal of Pharmacology 2004, 484:241-247.
231. Odmark I.S., Bixo M., Jonsson B., Bäckström T. Long term effects of two different continuous combined regimens of hormone replacement therapy on well being. Gynecological Endocrinology 2004, 18:305-317.
232. Osterlund M.K., Gustafsson J.A., Keller E., Hurd Y.L. Estrogen receptor β (ERβ) messenger ribonucleic acid (mRNA) expression within the human forebrain: Distinct distribution pattern to ERα mRNA. Journal of Clinical Endocrinology and Metabolism 2000, 85:3840-3846.
233. Padberg F., diMichele F., Zwanzger P., et al. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Neuropsychopharmacology 2002, 27:874-878. (erratum in: Neuropsychopharmacology 2003, 28: 610-611).
234. Papadopoulos V., Lecanu L., Brown R.C., Han Z., Yao Z.X. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 2006, 138:749-756.
235. Papodopoulos V., Guarneri P. Regulation of C6 glioma cell steroidogenesis by adenosine 3′,5′-cyclic monophosphate. Glia 1994, 10:75-78.
236. Parducz A., Hajszan T., Maclusky N.J., et al. Synaptic remodeling induced by gonadal hormones: Neuronal plasticity as a mediator of neuroendocrine and behavioral responses to steroids. Neuroscience 2006, 138:977-985. Review.
237. Paredes R.G., Vazquez B. What do female rats like about sex? Paced mating. Behavioural Brain Research 1999, 105:117-127.
238. Patchev V.K., Almeida O.F. Gonadal steroids exert facilitating and 'buffering' effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hormone and corticosteroid receptor genes in rat brain. Journal of Neuroscience 1996, 16:7077-7084.
239. Patchev V.K., Hassan A.H., Holsboer D.F., Almeida O.F. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 1996, 15:533-540.
240. Patchev V.K., Shoaib M., Holsboer F., Almeida O.F. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 1994, 62:265-271.
241. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB Journal 1992, 6:2311-2322.
242. Pearlstein T.B. Hormones and depression: What are the facts about premenstrual syndrome, menopause, and hormone replacement therapy?. American Journal of Obstetrics and Gynecology 1995, 173:646-653.
243. Pearlstein T.B., Bachmann G.A., Zacur H.A., Yonkers K.A. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005, 72:414-421.
244. Petanceska S.S., Nagy V., Frail D., Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Experimental Gerontology 2000, 35:1317-1325.
245. PfaffD.W., Gerlach J.L., McEwen B.S., Ferin M., Carmel P., Zimmerman E.A. Autoradiographic localization of hormone-concentrating cells in the brain of the female rhesus monkey. Journal of Comparative Neurology 1976, 170:279-293.
246. Pike C.J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: Relevance to Alzheimer's disease. Journal of Neurochemistry 1999, 72:1552-1563.
247. Pinna G., Dong E., Matsumoto K., Costa E., Guidotti A. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2035-2040.
248. A receptors: Immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000, 101:815-850.
249. Purdy R.H., Morrow A.L., Blinn J.R., Paul S.M. Synthesis, metabolism, and pharmacological activity of 3α-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. Journal of Medicinal Chemistry 1990, 33:1572-1581.
250. Purdy R.H., Morrow A.L., Moore P.H., Paul S.M. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:4553-4557.
251. Ramcharan S., Love E.J., Fick G.H., Goldfien A. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors. Journal of Clinical Epidemiology 1992, 45:377-392.
252. Rannevik G., Jeppsson S., Johnell O., Bjerre B., Laurell-Borulf Y., Svanberg L. A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995, 21:103-113.
253. Rapkin A.J., Mikacich J.A., Moatakef-Imani B., Rasgon N. The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Current Psychiatry Reports 2002, 4:419-428.
254. Rapkin A.J., Morgan M., Goldman L., Brann D.W., Simone D., Mahesh V.B. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstetrics and Gynecology 1997, 90:709-714.
255. Read J., Perry B.D., Moskowitz A., Connolly J. The contribution of early traumatic events to schizophrenia in some patients: A traumagenic neurodevelopmental model. Psychiatry 2001, 64:319-345.
256. Reddy D.S. The clinical potentials of endogenous neurosteroids. Drugs Today (Barc) 2002, 38:465-485.
257. Reddy D.S. Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?. Trends in Pharmacological Sciences 2003, 24:103-106.
258. Reddy D.S. Pharmacology of catamenial epilepsy. Methods and Findings in Experimental Clinical Pharmacology 2004, 26:547-561.
259. Rhodes M.E., Frye C.A. Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cognitive, Affective & Behavioral Neuroscience 2001, 1:287-296.
260. Rhodes M.E., Frye C.A. Attenuating 5alpha-pregnane-3alpha-ol-20-one formation in the hippocampus of female rats increases pentylenetetrazole-induced seizures. Epilepsy and Behavior 2005, 6:140-146.
261. A receptors in the hippocampus may mediate some antiseizure effects of progestins. Epilepsy and Behavior 2005, 6:320-327.
262. Romeo E., Ströhle A., Spalletta G., et al. Effects of antidepressant treatment on neuroactive steroids in major depression. American Journal of Psychiatry 1998, 155:910-913.
263. Rościszewska D., Buntner B., Guz I., Zawisza L. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 1986, 49:47-51.
264. Rougé-Pont F., Mayo W., Marinelli M., Gingras M., Le Moal M., Piazza P.V. The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens. European Journal of Neuroscience 2002, 16:169-173.
265. Roxburgh A., Degenhardt L., Copeland J. Posttraumatic stress disorder among female street-based sex workers in the greater Sydney area, Australia. BMC Psychiatry 2006, 6:24.
266. Rubin R.T., Poland R.E., Lesser I.M., Martin D.J., Blodgett A.L., Winston R.A. Neuroendocrine aspects of primary endogenous depression. III: Cortisol secretion in relation to diagnosis and symptom patterns. Psychological Medicine 1987, 17:609-619.
267. Rubin R.T., Poland R.E., Lesser I.M., Winston R.A., Blodgett A.L. Neuroendocrine aspects of primary endogenous depression. I: Cortisol secretory dynamics in patients and matched controls. Archives of General Psychiatry 1987, 44:328-336.
268. Rubinow D.R., Hoban M.C., Grover G.N., Galloway D.S., Roy-Byrne P., Andersen R., Merriam G.R. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. American Journal of Obstetrics and Gynecology 1988, 158:5-11.
269. Rupprecht R., Holsboer F. Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives. Trends in Neurosciences 1999, 22:410-416.
270. Russell J.A., Leng G., Douglas A.J. The magnocellular oxytocin system, the fount of maternity: Adaptations in pregnancy. Frontiers in Neuroendocrinology 2003, 24:27-61. Review.
271. Russo S.J., Festa E.D., Fabian S.J., Gazi F.M., Kraish M., Jenab S., Quinones-Jenab V. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience 2003, 120:523-533.
272. Sanders D., Warner P., Bäckström T., Bancroft J. Mood, sexuality, hormones and the menstrual cycle. I: Changes in mood and physical state: Description of subjects and method. Psychosomatic Medicine 1983, 45:487-501.
273. Satzinger G. Antiepileptics from gamma-aminobutyric acid. Arzneimittelforschung 1994, 44:261-266.
274. Schlegel M.L., Spetz J.F., Robel P., Haug M. Studies on the effects of dehydroepiandrosterone and its metabolites on attack by castrated mice on lactating intruders. Physiology and Behavior 1985, 34:867-870.
275. Schlinger B.A., London S.E. Neurosteroids and the songbird model system. Journal of Experimental Zoology A: Comparative Experimental Biology 2006, 305:743-748.
276. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New England Journal of Medicine 1998, 338:209-216.
277. Schmidt P.J., Purdy R.H., Moore P.H., Paul S.M., Rubinow D.R. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. Journal of Clinical Endocrinology and Metabolism 1994, 79:1256-1260.
278. Schneider J.S., Burgess C., Sleiter N.C., Doncarlos L.L., Lydon J.P., O'Malley B., Levine J.E. Enhanced sexual behaviors and androgen receptor immunoreactivity in the male progesterone receptor knockout mouse. Endocrinology 2005, 146:4340-4348.
279. Schüle C., diMichele F., Baghai T., et al. Influence of sleep deprivation on neuroactive steroids in major depression. Neuropsychopharmacology 2003, 28:577-581.
280. Schumacher M., Akwa Y., Guennoun R., et al. Steroid synthesis and metabolism in the nervous system: Trophic and protective effects. Journal of Neurocytology 2000, 29:307-326. Review.
281. Schumacher M., Guennoun R., Mercier G., et al. Progesterone synthesis and myelin formation in peripheral nerves. Brain Research. Brain Research Review 2001, 37:343-359. Review.
282. Schumacher M., Weill-Engerer S., Liere P., et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Progress in Neurobiology 2003, 71:3-29.
283. Schwartz-Giblin S., PfaffD.W. Hypothalamic output controlling reticulospinal and vestibulospinal systems important for emotional behavior. International Journal of Neurology 1985-1986, 19-20. 89-110.
284. Segovia J., Lawless G.M., Tillakaratne N.J., Brenner M., Tobin A.J. Cyclic AMP decreases the expression of a neuronal marker (GAD67) and increases the expression of an astroglia marker (GFAP) in C6 cells. Journal of Neurochemistry 1994, 63:1218-1225.
285. Seippel L., Bäckström T. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. Journal of Clinical Endocrinology and Metabolism 1998, 83:1988-1992.
286. Selye H. Anesthetic effects of steroid hormones. Proceedings of the Society for Experimental and Biological Medicine 1941, 46:116-121.
287. Serra M., Pisul M.G., Dazzi L., Purdy R.H., Biggio G. Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine. Journal of Psychopharmacology 2002, 16:133-138.
288. Shain W., Bausback D., Fiero A., Madelian V., Turner J.N. Regulation of receptor-mediated shape change in astroglial cells. Glia 1992, 5:223-238.
289. Sherwin B.B. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. Journal of Affective Disorders 1988, 14:177-187.
290. Sherwin B.B., Gelfand M.M. A prospective one-year study of estrogen and progestin in postmenopausal women: Effects on clinical symptoms and lipoprotein lipids. Obstetrics and Gynecology 1989, 73:759-766.
291. Shirayama Y., Hashimoto K., Suzuki Y., Higuchi T. Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophrenia Research 2002, 58:69-74.
292. Shughrue P.J., Lane M.V., Merchenthaler I. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: An in situ hybridization study. Endocrinology 1997, 138:5476-5484.
293. Shumaker SA, Legault C, Rapp SR, et al. (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association 289: 2651-2562.
294. Sinchak K., Mills R.H., Tao L., LaPolt P., Lu J.K., Miceyvych P. Estrogen induces de novo progesterone synthesis in astrocytes. Developmental Neuroscience 2003, 5:343-348.
295. Sinha R., Lacadie C., Skudlarski P., Fulbright R.K., Rounsaville B.J., Kosten T.R., Wexler B.E. Ural activity associated with stress-induced cocaine craving: A functional magnetic resonance imaging study. Psychopharmacology (Berl) 2005, 183:171-180.
296. Sinha R., Talih M., Malison R., Cooney N., Anderson G.M., Kreek M.J. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 2003, 170:62-72.
297. Sinnott R.S., Phillips T.J., Finn D.A. Alteration of voluntary ethanol and saccharin consumption by the neurosteroid allopregnanolone in mice. Psychopharmacology (Berl) 2002, 162:438-447.
298. Smith C.D., Wekstein D.R., Markesbery W.R., Frye C.A. 3alpha,5alpha-THP: A potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia. Psychopharmacology (Berl) 2006, 186:481-485.
299. Soares C.N., Cohen L.S., Otto M.W., Harlow B.L. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: A preliminary report from the Harvard Study of Moods and Cycles. Journal of Women's Health and Gender-Based Medicine 2001, 10:873-878.
300. Sofuoglu M., Mitchell E., Kosten T.R. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacology, Biochemistry, and Behavior 2004, 78:699-705.
301. Soma K.K., Sinchak K., Lakhter A., Schlinger B.A., Micevych P.E. Neurosteroids and female reproduction: Estrogen increases 3β-HSD mRNA and activity in rat hypothalamus. Endocrinology 2005, 146:4386-4390.
302. Sora I., Wichems C., Takahashi N., et al. Cocaine reward models: Conditioned place preference can be established in dopamine and in serotonin-transporter knockout mice. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:7699-7704.
303. Spalletta G., Romeo E., Bonaviri G., Bernardi G., Caltagirone C., di Michele F. Preliminary evidence for an association between aggressive and hostile behaviour and 3α,5α-tetrahydroprogesterone plasma levels in schizophrenia. Journal of Psychiatry and Neuroscience 2005, 30:49-52.
304. Stahl S.M. Sex therapy in psychiatric treatment has a new partner: Reproductive hormones. Journal of Clinical Psychiatry 1997, 58:468-469.
305. Stell B.M., Brickley S.G., Tang C.Y., Farrant M., Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:14439-14444.
306. Stewart A.L., Reynolds E.O., Hope P.L., et al. Probability of neurodevelopmental disorders estimated from ultrasound appearance of brains of very preterm infants. Developmental medicine and child neurology 1987, 29:3-11.
307. Stewart A.L., Thorburn R.J., Hope P.L., Goldsmith M., Lipscomb A.P., Reynolds E.O. Ultrasound appearance of the brain in very preterm infants and neurodevelopmental outcome at 18 months of age. Archives of Disease in Childhood 1983, 58:598-604.
308. Ströhle A., Romeo E., di Michele F., et al. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: Preliminary results. Archives of General Psychiatry 2003, 60:161-168.
309. Strous R.D., Maayan R., Lapidus R., Stryjer R., Lustig M., Kotler M., Weizman A. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Archives of General Psychiatry 2003, 60:133-141.
310. Strous R.D., Maayan R., Weizman A. The relevance of neurosteroids to clinical psychiatry: From the laboratory to the bedside. European Neuropsychopharmacology 2006, 16:155-169.
311. Sullivan S.D., Moenter S.M. Neurosteroids alter gamma-aminobutyric acid postsynaptic currents in gonadotropin-releasing hormone neurons: A possible mechanism for direct steroidal control. Endocrinology 2003, 144:4366-4375.
312. Sundström I., Andersson A., Nyberg S., Ashbrook D., Purdy R.H., Bäckström T. Patients with premenstrual syndrome have a different sensitivity to a neuroactive-steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998, 67:126-138.
313. Sundström I., Ashbrook D., Bäckström T. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: A pilot study. Psychoneuroendocrinology 1997, 22:2538.
314. Sundström I., Bäckström T. Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: An open trial. Psychoneuroendocrinology 1998, 23:73-88.
315. Sundström I., Bäckström T. Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects. Biological Psychiatry 1998, 44:755-764.
316. Sundström I., Bäckström T., Wang M., Olsson T., Seippel L., Bixo M. Premenstrual syndrome, neuroactive steroids and the brain. Gynecological Endocrinology 1999, 13:206-220.
317. Sundström I., Nyberg S., Bäckström T. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 1997, 17:370-381.
318. Sveindottir H., Bäckström T. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstetricia et Gynecologica Scandinavica 2000, 79:405-413.
319. Tait G.R., McManus K., Bellavance F., Lara N., Chrapko W., LeMellédo J.M. Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin. Psychoneuroendocrinology 2002, 27:417-429.
320. Tanapat P., Hastings N.B., Gould E. Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose- and time-dependent manner. Journal of Comparative Neurology 2005, 481:252-265.
321. Tordjman S., Anderson G.M., McBride P.A., et al. Plasma androgens in autism. Journal of Autism and Developmental Disorders 1995, 25:295-304.
322. Torres J.M., Ortega E. Alcohol intoxication increases allopregnanolone levels in female adolescent humans. Neuropsychopharmacology 2003, 28:1207-1209.
323. Torres J.M., Ortega E. Alcohol intoxication increases allopregnanolone levels in male adolescent humans. Psychopharmacology (Berl) 2004, 172:352-355.
324. Townsend K.A., Marlowe K.F. Relative safety and efficacy of finasteride for treatment of hirsutism. Annals of Pharmacotherapy 2004, 38:1070-1073.
325. Uchida S., Noda E., Kakazu Y., Mizoguchi Y., Akaike N., Nabekura J. Allopregnanolone enhancement of GABAergic transmission in rat medial preoptic area neurons. AJP - Endocrinology and Metabolism 2002, 283:1257-1265.
326. Uzunov D.P., Cooper T.B., Costa E., Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:12599-12604.
327. Uzunova V., Sampson L., Uzunov D.P. Relevance of endogenous 3α-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl) 2006, 186:351-361.
328. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proceedings of the National Academy of Sciences of the United States of America 1998, 5:3239-3244.
329. Uzunova V., Wrynn A.S., Kinnunen A., Ceci M., Kohler C., Uzunov D.P. Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. European Journal of Pharmacology 2004, 486:31-34.
330. Verleye M., Akwa Y., Liere P., et al. The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. Pharmacology, Biochemistry, and Behavior 2005, 82:712-720.
331. Voigt L.F., Weiss N.S., Chu J., Daling J.R., McKnight B., van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991, 338:274-277.
332. Vongher J.M., Frye C.A. Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration. Pharmacology, Biochemistry, and Behavior 1999, 64:777-785.
333. Walf A.A., Frye C.A. A review and update: Estrogen's effects, brain targets, and mechanisms for anxiety and depression behavior. Neuropsychopharmacology 2006, 31:1097-1111.
334. Wang M., Bäckström T., Sundström I., et al. Neuroactive-steroids and central nervous system disorders. International Review of Neurobiology 2001, 46:421-459.
335. Wang J.M., Johnston P.B., Ball B.G., Brinton R.D. The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. Journal of Neuroscience 2005, 25:4706-4718.
336. Wang M., Seippel L., Purdy R.H., Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. Journal of Clinical Endocrinology and Metabolism 1996, 81:1076-1082.
337. Weill-Engerer S., David J.P., Sazdovitch V., et al. Neurosteroid quantification in human brain regions: Comparison between Alzheimer's and nondemented patients. Journal of Clinical Endocrinology and Metabolism 2002, 87:5138-5143.
338. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Progress in Neurobiology 2001, 65:427-451.
339. Weinstock M. The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behavior Immunity 2005, 19:296-308.
340. Weir C.J., Ling A.T., Belelli D., Wildsmith J.A., Peters J.A., Lambert J.J. The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors. British Journal of Anaesthesia 2004, 92:704-711.
341. Weissman M.M., Klerman G.L. The chronic depressive in the community: Unrecognized and poorly treated. Comprehensive Psychiatry 1977, 18:523-532.
342. Whitehead M.I. The effects of oestrogens and progestogens on the postmenopausal endometrium. Maturitas 1978, 1:87-98.
343. Whiting P.J. The GABA-A receptor gene family: New targets for therapeutic intervention. Neurochemistry International 1999, 34:387-390.
344. Whiting P.J., Bonnert T.P., McKernan R.M., et al. Molecular and functional diversity of the expanding GABA-A receptor gene family. Annals of the New York Academy of Sciences 1999, 868:645-653.
345. Wiebe J.P., Boushy D., Wolfe M. Synthesis, metabolism and levels of the neuroactive steroid, 3alpha-hydroxy-4-pregnen-20-one (3alphaHP), in rat pituitaries. Brain Research 2005, 764:158-166.
346. Wihlbäck A.C., Nyberg S., Bäckström T., Bixo M., Sundström-Poromaa I. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women. Psychoneuroendocrinology 2005, 30:38-50.
347. Wihlbäck A.C., Sundström-Poromaa I., Nyberg S., Bäckström T. Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy. Neuroendocrinology 2001, 73:397-407.
348. Wiklund I., Karlberg J., Mattsson L.Å. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study. American Journal of Obstetrics and Gynecology 1993, 168:824-830.
349. Wittchen H.U., Essau C.A., von Zerssen D., Krieg J.C., Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study. European Archives of Psychiatry and Clinical Neuroscience 1992, 241:247-258.
350. A receptors containing the delta subunit. Journal of Neuroscience 2002, 22:1541-1549.
351. Woodbury D.M. Experimental models of status epilepticus and mechanisms of drug action. Advances in Neurology 1983, 34:149-160.
352. Xu H., Gouras G.K., Greenfield J.P., et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nature Medicine 1998, 4:447-451.
353. Yamashita M., Fukushima S., Shen H.W., et al. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology 2006, 31:2132-2139.
354. Yawno T., Yan E.B., Walker D.W., Hirst J.J. Inhibition of neurosteroid synthesis increases asphyxia-induced brain injury in the late gestation fetal sheep. Neuroscience 2007, 146:1726-1733.
355. Yoon B.K., Kim D.K., Kang Y., Kim J.W., Shin M.H., Na D.L. Hormone replacement therapy in postmenopausal women with Alzheimer's disease: A randomized, prospective study. Fertility and Sterility 2003, 79:274-280.
356. Young E., Carlson N.E., Brown M.B. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology 2001, 25:267-276.
357. Young L.T. Neuroprotective effects of antidepressant and mood stabilizing drugs. Journal of Psychiatry and Neuroscience 2002, 27:8-9.
358. Young E.A., Midgley A.R., Carlson N.E., Brown M.B. Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Archives of General Psychiatry 2000, 57:1157-1162.
359. Zheng H., Xu H., Uljon S.N., et al. Modulation of A(beta) peptides by estrogen in mouse models. Journal of Neurochemistry 2002, 80:191-196.
360. Zhu Y., Bond J., Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2237-2242.
361. Zuluaga M.J., Agrati D., Pereira M., Uriarte N., Fernandez-Guasti A., Ferreira A. Experimental anxiety in the black and white model in cycling, pregnant and lactating rats. Physiology and Behavior 2005, 84:279-286.
362. Zwanzger P., Eser D., Padberg F., et al. Neuroactive steroids are not affected by panic induction with 50microg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers. Journal of Psychiatric Research 2004, 8:215-217.
363. Akwa Y., Baulieu E.E., David J.P., et al. Neurosteroid quantification in human brain regions: Comparison between Alzheimer's and nondemented patients. Journal of Clinical Endocrinology and Metabolism 2002, 87:5138-5143.
364. Alexaki V.I., Castanas E., Charalampopoulos I., et al. Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging. Annals of the New York Academy of Sciences 2006, 1088:139-152.
365. Altura B.M., Altura B.T., Li W. Sex steroid hormones exert biphasic effects on cytosolic magnesium ions in cerebral vascular smooth muscle cells: Possible relationships to migraine frequency in premenstrual syndromes and stroke incidence. Brain Research Bulletin 2001, 54:83-89.
366. Behl C., Holsboer F., Lezoualc'h F., et al. Estrogen modulates neuronal Bcl-xL expression and β-amyloid-induced apoptosis: Relevance to Alzheimer's disease. Journal of Neurochemistry 1999, 72:1552-1563.
367. Bian F., Callahan M.J., Durham R.A., Lipinski W.J., Pack A., Walker L.C. Augmented senile plaque load in aged female β-amyloid precursor protein-transgenic mice. American Journal of Pathology 2001, 158:1173-1177.
368. Buntner B., Guz I., Rościszewska D., Zawisza L. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 1986, 49:47-51.
369. Buxbaum J.D., Chait B.T., Checler F., et al. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nature Medicine 1998, 4:447-451.
370. Cadet J.L., Deng X., Ladenheim B., Noailles P.A., Jayanthi S. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB Journal 2004, 18:238-251.
371. Carrero P., Ciriza I., Frye C.A., Garcia-segure L.M. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. Journal of Neurobiology 2006, 66:916-928.
372. Carroll B.J., Curtis G.C., Mendels J. Neuroendocrine regulation in depression. I: Limbic system-adrenocortical dysfunction. Archives of General Psychiatry 1976, 33:1039-1044.
373. Carroll B.J., Curtis G.C., Mendels J. Neuroendocrine regulation in depression. II: Discrimination of depressed from nondepressed patients. Archives of General Psychiatry 1976, 33:1051-1058.
374. Cavarretta I., Galbiati M., Magnaghi V., Martini L., Melcangi R.C. Neuroactive steroids and peripheral myelin proteins. Brain Research Reviews 2001, 37:360-371.
375. Csakvari E., Hajszan T., Hoyk Z., et al. Synaptic remodeling induced by gonadal hormones: Neuronal plasticity as a mediator of neuroendocrine and behavioral responses to steroids. Neuroscience 2006, 138:977-985.
376. Daniel J.M. Effects of oestrogen on cognition: What have we learned from basic research?. Journal of Neuroendocrinology 2006, 18:787-795.
377. DuffK., Gaynor J., Gross R., et al. Modulation of A(β) peptides by estrogen in mouse models. Journal of Neurochemistry 2002, 80:191-196.
378. Frail D., Ganday S., Nagy V., Petanceska S.S. Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain. Experimental Gerontology 2000, 35:1317-1325.
379. Freeman E.W., Frye C.A., Rickels K., Martin P.A., Smith S.S. Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. Journal of Clinical Psychopharmacology 2002, 22:516-520.
380. Frye C.A., Herzog A.G. Seizure exacerbation associated with inhibition of progesterone metabolism. Annals of Neurology 2003, 53:390-391.
381. Gray A. Serotonin in the basal ganglia: Functions and interactions with other neuronal pathways. Journal of Physiology (Paris) 1981, 77:393-403.
382. Green P.S., Simpkins J.W., Yang S.H. Neuroprotective effects of phenolic A ring oestrogens. Novartis Foundation Symposium 2000, 230:202-213.
383. A receptor subunit levels in association with increased anxiety in the female rat. Brain Research 2001, 910:55-66.
384. Hao J., Janssen W.G., Tang Y., et al. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. Journal of Comparative Neurology 2003, 465:540-550.
385. Hastings N.B., Gould E., Tanapat P. Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose- and time-dependent manner. Journal of Comparative Neurology 2005, 481:252-265.
386. Janowsky J.S. The role of androgens in cognition and brain aging in men. Neuroscience 2005, 138:15-20.
387. Janowsky J.S. Thinking with your gonads: Testosterone and cognition. Trends in Cognitive Sciences 2006, 10:77-82.
388. Melton L. What can sex hormones do for the damaged brain?. Lancet 2001, 358:818.
389. Micevych P.E., Chaban V., Ogi J., Dewing P., Lu J.K., Sinchak K. Estradiol stimulates progesterone synthesis in hypothalamic astrocyte cultures. Endocrinology 2007, 148:782-789.
390. Micevych P., Sinchak K., Mills R.H., Tao L., LaPolt P., Lu J.K. The luteinizing hormone surge is preceded by an estrogen-induced increase of hypothalamic progesterone in ovariectomized and adrenalectomized rats. Neuroendocrinology 2007, 78:29-35.
391. Nilsen J., Irwin R.W., Gallaher T.K., Brinton R.D. Estradiol in vivo regulation of brain mitochondrial proteome. Journal of Neuroscience 2007, 27:4069-4077.
392. Roberts D.C., Bennett S.A., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology 1989, 98:408-411.
393. Sato T., Teramoto T., Tanaka K., Ohnishi Y., Irifune M., Nishikawa T. Effects of ovariectomy and calcium deficiency on learning and memory of eight-arm radial maze in middle-aged female rats. Behavioural Brain Research 2003, 142:207-216.
394. Sherwin B.B., Henry J.F. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review. Front Neuroendocrinology 2008, 29:88-113.
395. Shirayama Y., Hashimoto K., Suzuki Y., Higuchi T. Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophrenia Research 2002, 58:69-74.
396. Veiga S., Melcangi R.C., Doncarlos L.L., Garcia-Segura L.M., Azcoitia I. Sex hormones and brain aging. Experimental Gerontology 2004, 39:1623-1631.
397. Wang J.M., Liu L., Irwin R.W., Chen S., Brinton R.D. Regenerative potential of allopregnanolone. Brain Research Reviews 2008, 57:398-409.
398. Wei W., Faria L.C., Mody I. Low ethanol concentrations selectively augment the tonic inhibition mediated by delta subunit-containing GABAA receptors in hippocampal neurons. Journal of Neuroscience 2004, 24:8379-8382.